Cognitive performance in recreational users of MDMA or 'ecstasy': Evidence for memory deficits

Journal of Psychopharmacology

Volumn 12, Issue 1, 1998, Pages 79-83

  Parrott, A C ^a   Lees, A ^a   Garnham, N J ^a   Jones, M ^a   Wesnes, K ^b  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b Cognitive Drug Research ^*  (United Kingdom)

Author keywords

'ecstasy'; Cognition; Memory; Methylenedioxymethamphetamine; Performance; Psychoactive drug; Recreational drug

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ALERTNESS; AMNESIA; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MALE; NERVE DEGENERATION; NEUROTOXICITY; PERFORMANCE; PRIORITY JOURNAL; REACTION TIME; RESPONSE TIME; SEROTONINERGIC NERVE CELL; TASK PERFORMANCE; VELOCITY; WORD RECOGNITION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COGNITION; FEMALE; HALLUCINOGENS; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REACTION TIME; STREET DRUGS;

EID: 0031915719     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200110     Document Type: Article

References (25)

1. Curran H V, Travill R A (1997) Mood and cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 92: 821-831
2. Curran H V (1998) Future perspectives for psychological research on MDMA ('ecstasy'). J Psychopharmac 12: 105 (abstract)
3. Davison D, Parrott A C (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmac 12: 91-97
4. Frederick D L, Paule M G (1997) Effects of MDMA on complex brain function in laboratory animals. Neurosci Biobehav Rev 21: 67-78
5. Frederick D L, Ali S F, Slikker W, Gillam M P, Allen P R, Paule M G (1995) Behavioural and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in Rhesus monkeys. Neurotoxicol Teratol 17: 531-543
6. Green A R, Cross A J, Goodwin G M (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or 'Ecstasy'). Psychopharmacology 119: 247-260
7. Krystal J H, Price L H, Opsahl C, Ricaurte G A, Heninger G R (1992) Chronic 3.4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18: 331-341
8. Liester M B, Grob C S, Bravo G L, Walsh R N (1992) Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use. J Nerv Ment Dis 180: 345-352
9. Maxwell D L, Polkey M I, Henry J A (1994) Hyponatraemia and catatonic stupor after taking 'ecstasy'. BMJ 307: 1399
10. McCann U D, Ricaurte A (1991) Lasting neuropsychiatric sequelae of methylenedioxymethamphetamine ('ecstasy') in recreational users. J Clin Psychopharmac 11: 302-305
11. McCann U D, Ridenour A, Shaham Y, Ricaurte G A (1994) Serotonin neurotoxicity after 3.4-methylenedioxymethamphetamine (MDMA; ecstasy): a controlled study in humans. Neuropsychopharmacology 10: 129-138
12. McCann U D, Slate S O, Ricaurte G A (1996) Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'). Drug Safety 15: 107-115
13. Morgan M J (1998) Lasting psychological sequelae of recreational use of MDMA ('ecstasy'): controlled studies in humans. J Psychopharmac 12: 105-106 (abstract)
14. Parrott A C (1995) Psychoactive drugs of use and abuse: wobble, rave, inhale, or crave? J Psychopharmac 9: 390-391
15. Parrott A C (1997) MDMA, mood and memory: the agnosia of the ecstasy. Br Psychol Soc Proc 5: 49
16. Parrott A C (1998) The psychobiology of MDMA or 'ecstasy': symposium report. J Psychopharmac 12: 101-106
17. Parrott A C, Stuart M (1997) Comparative mood effects of MDMA (ecstasy), LSD, and amphetamine, in polydrug users. Hum Psychopharmac 12 in press
18. Parrott A C, Garnham N J, Wesnes K, Pincock C (1996) Cigarette smoking and abstinence: comparative effects upon cognitive task performance and mood state over 24 hours. Hum Psychopharmac 11: 391-400
19. Peroutka S J, Newman H, Harris H (1988) Subjective effects of 3.4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology1: 273-277
20. Ricaurte G A, McCann U D (1992) Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann NY Acad Sci 648: 371-382
21. Ricaurte G A, Martello A L, Katz J L, Martello M B (1992) Lasting effects of 3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurones in nonhuman primates: neurochemical observations. J Pharmac Exp Ther 261: 616-622
22. Saunders (1995) Ecstasy and the dance culture. Neal'sYard Desktop Publishing, London
23. Series H, Boeles S, Dorkins E, Peveler R (1994) Psychiatric complications of 'ecstasy'. J Psychopharmac 8: 60-61
24. Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of ecstasy users and their experience with the drug. Br J Addict 87: 1161-1172
25. Steele T D, McCann U D, Ricaurte G A (1994) 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy'): pharmacology and toxicology in animals and humans. Addiction 89: 539-551